THE EFFECTS OF MDMA-ASSISTED THERAPY ON ALCOHOL AND SUBSTANCE USE IN A PHASE 3 TRIAL FOR TREATMENT OF SEVERE PTSD
Drug and Alcohol Dependence February 1, 2022 Christopher R. Nicholas, Julie B. Wang, Allison R. Coker et al. 67 citations
Background Post-traumatic stress disorder (PTSD) is commonly associated with alcohol and substance use disorders (ASUD). A randomized, placebo-controlled, phase 3 trial demonstrated the safety and efficacy of MDMA-assisted therapy (MDMA-AT) for the treatment of severe PTSD. This analysis explores patterns of alcohol and substance use in patients receiving MDMA-AT compared to placebo plus...